title: Myxedema-associated cardiogenic shock treated with intravenous triiodothyronine.
authors.affiliation: University of New Mexico, Albuquerque.
authors.forename: S D
authors.initials: SD
authors.lastname: MacKerrow
authors.forename: L A
authors.initials: LA
authors.lastname: Osborn
authors.forename: H
authors.initials: H
authors.lastname: Levy
authors.forename: R P
authors.initials: RP
authors.lastname: Eaton
authors.forename: P
authors.initials: P
authors.lastname: Economou
mesh_terms: D000284:Administration, Oral; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D009230:Myxedema / Q000150:complications* / Q000188:drug therapy; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology*; D013974:Thyroxine / Q000627:therapeutic use; D014284:Triiodothyronine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014284:Triiodothyronine; D013974:Thyroxine